|
1
|
Aguayo A, Garcia-Alvarez E,
Cazares-Ordonez Y, Crespo-Solis E, Martinez-Baños D,
Guadarrama-Beltran E, Cervera-Ceballos EE and Lopez-Karpovitch X:
Chronic myeloid leukemia: A clinicoepidemiologic and therapeutic
description of a single institution in Mexico city. Clin Leuk.
2:261–266. 2008. View Article : Google Scholar
|
|
2
|
Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar
S, Kim DW, Kweon IY, O'Neil WM, Saikia TK and Wang J: Chronic
myeloid leukemia in Asia. Int J Hematol. 89:14–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Faderl S, Talpaz M, Estrov Z, O'Brien S,
Kurzrock R and Kantarjian HM: The biology of chronic myeloid
leukemia. N Engl J Med. 341:164–172. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cowan-Jacob SW, Fendrich G, Floersheimer
A, Furet P, Liebetanz J, Rummel G, Rheinberger P, Centeleghe M,
Fabbro D and Manley PW: Structural biology contributions to the
discovery of drugs to treat chronic myelogenous leukaemia. Acta
Crystallogr D Biol Crystallogr. 63:80–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sessarego M, Fugazza G, Bruzzone R,
Ballestrero A, Miglino M and Bacigalupo A: Complex chromosome
rearrangements may locate the Bcr/abl fusion gene sites other than
22q11. Haematologica. 85:35–39. 2000.PubMed/NCBI
|
|
6
|
La Starza R, Testoni N, Lafage-Pochitaloff
M, Ruggeri D, Ottaviani E, Perla G, Martelli MF, Marynen P and
Mecucci C: Complex variant Philadelphia translocations involving
the short arm of chromosome 6 in chronic myeloid leukemia.
Haematologica. 87:143–147. 2002.PubMed/NCBI
|
|
7
|
Achkar WA, Wafa A, Ali BY, Manvelyan M and
Liehr T: A rare chronic myeloid leukemia case with Philadelphia
chromosome, BCR-ABL e13a3 transcript and complex translocation
involving four different chromosomes. Oncol Lett. 1:797–800. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Al-Achkar W, Wafa A and Liehr T: A new
t(9;11;20;22)(q34;p11.2;q11.21;q11) in a Philadelphia-positive
chronic myeloid leukemia case. Oncol Lett. 5:605–608.
2013.PubMed/NCBI
|
|
9
|
Cohen MH, Williams G, Johnson JR, Duan J,
Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, et al:
Approval summary for imatinib mesylate capsules in the treatment of
chronic myelogenous leukemia. Clin Cancer Res. 8:935–942.
2002.PubMed/NCBI
|
|
10
|
Koshiyama DB, Capra ME, Paskulin GA, Rosa
RF, Oliveira CA, Vanelli T, Fogliatto LM and Zen PR: Cytogenetic
response to imatinib treatment in Southern Brazilian patients with
chronic myelogenous leukemia and variant Philadelphia chromosome.
Ann Hematol. 92:185–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cortes J, Giles F, O'Brien S, Thomas D,
Garcia-Manero G, Rios MB, Faderl S, Verstovsek S, Ferrajoli A,
Freireich EJ, et al: Result of high-dose imatinib mesylate in
patients with Philadelphia chromosome-positive chronic myeloid
leukemia after failure of interferon-α. Blood. 102:83–86. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simons A, Shaffer LG and Hastings RJ:
Cytogenetic nomenclature: Changes in the ISCN 2013 compared to the
2009 edition. Cytogenet Genome Res. 141:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bennour A, Sennana H, Laatiri MA, Elloumi
M, Khelif A and Saad A: Molecular cytogenetic characterization of
variant Philadelphia translocations in chronic myeloid leukemia:
Genesis and deletion of derivative chromosome 9. Cancer Genet
Cytogenet. 194:30–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dubé I, Dixon J, Beckett T, Grossman A,
Weinstein M, Benn P, McKeithan T, Norman C and Pinkerton P:
Location of breakpoints within the major breakpoint cluster region
(bcr) in 33 patients with bcr rearrangement-positive chronic
myeloid leukemia (CML) with complex or absent Philadelphia
chromosomes. Genes Chromosomes Cancer. 1:106–111. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagemeijer A: The Philadelphia chromosome,
25 years later. 1960–1985. Nouv Rev Fr Hematol. 27:153–155.
1985.(In French). PubMed/NCBI
|
|
17
|
Potter AM, Sharp JC, Brown MJ and Sokol
RJ: Structural rearrangements associated with the Ph1 chromosome in
chronic granulocytic leukaemia. Humangenetik. 29:223–228.
1975.PubMed/NCBI
|
|
18
|
La Starza R, Vitale A, Serra A, Saglio G,
Fioritoni G, Falzetti D, Martelli MF, Foà R and Mecucci C:
Philadelphia-positive acute lymphoblastic leukemia with multiple
subclones including duplication of the Philadelphia chromosome and
Abelson oncogene. Cancer Genet Cytogenet. 132:46–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sessarego M, Ajmar F, Scarrà Bianchi GL,
Ravazzolo R, Garré C and Boccaccio P: Unusual Ph translocations in
CML: Four new cases. Cancer Genet Cytogenet. 15:199–207. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sessarego M, Defferrari R, Panarello C,
Frassoni F, Mandich P and Ajmar F: Variant Philadelphia
translocations in CML: Correlation with fragile sites. Cancer Genet
Cytogenet. 31:105–112. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Orciuolo E, Buda G, Galimberti S, Cervetti
G, Cecconi N, Papineschi F and Petrini M: Complex translocation
t(6;9;22)(p21.1;q34;q11) at diagnosis is a therapy resistance index
in chronic myeloid leukaemia. Leuk Res. 32:190–191. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reid R, de Silva MVC and Paterson L:
Poorly differentiated extraskeletal myxoid chondrosarcoma with
t(9;22)(q22;q11) translocation presenting initially as a solid
variant devoid of myxoid areas. Int J Surg Pathol. 11:137–141.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Legues ME, Encina A, Valenzuela M, Palma T
and Undurraga MS: Cytogenetic and molecular characteristics of 25
Chilean patients with a variant Ph translocation. Cancer Genet.
204:410–412. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barbouti A, Johansson B, Höglund M,
Mauritzson N, Strömbeck B, Nilsson PG, Tanke HJ, Hagemeijer A,
Mitelman F and Fioretos T: Multicolor COBRA-FISH analysis of
chronic myeloid leukemia reveals novel cryptic balanced
translocations during disease progression. Genes Chromosomes
Cancer. 35:127–137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zangari M, Anaissie E, Stopeck A, Morimoto
A, Tan N, Lancet J, Cooper M, Hannah A, Garcia-Manero G, Faderl S,
et al: Phase II study of SU5416, a small molecule vascular
endothelial growth factor tyrosine kinase receptor inhibitor, in
patients with refractory multiple myeloma. Clin Cancer Res.
10:88–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Quintás-Cardama A and Cortes JE: Chronic
myeloid leukemia: Diagnosis and treatment. Mayo Clin Proc.
81:973–988. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aliano S, Cirmena G, Fugazza G, Bruzzone
R, Palermo C and Sessarego M: Standard and variant Philadelphia
translocation in a CML patient with different sensitivity to
imatinib therapy. Leuk Res Rep. 2:75–78. 2013.PubMed/NCBI
|
|
28
|
Morel F, Herry A, Le Bris MJ, Morice P,
Bouquard P, Abgrall JF, Berthou C and De Braekeleer M: Contribution
of fluorescence in situ hybridization analyses to the
characterization of masked and complex Philadelphia chromosome
translocations in chronic myelocytic leukemia. Cancer Genet
Cytogenet. 147:115–120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reddy KS and Sulcova V: A FISH study of
variant Philadelphia rearrangements. Cancer Genet Cytogenet.
118:121–131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cohen MS, Hussain HB and Moley JF:
Inhibition of medullary thyroid carcinoma cell proliferation and
RET phosphorylation by tyrosine kinase inhibitors. Surgery.
132:960–967. 2002. View Article : Google Scholar : PubMed/NCBI
|
